Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
52 hedge funds and large institutions have $44.5M invested in Psychemedics Corporation in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 54 → 52 (-2)
10% less capital invested
Capital invested by funds: $49.4M → $44.5M (-$4.86M)
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q1 2019 in Review
52 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q1 2019, worth a combined $44.5M — down 9.8% from $49.4M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PMD and 1 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 15 added.
The largest buyer was Kennedy Capital Management, adding an estimated $1.36M. The largest seller was LSV Asset Management, exiting entirely with an estimated $531K sold.
- 52 institutional investors held Psychemedics Corporation (PMD) as of Q1 2019, down from 54 in Q4 2018.
- Funds reported $44.5M of Psychemedics Corporation stock for Q1 2019, down 9.8% quarter-over-quarter.
- 1 fund opened new Psychemedics Corporation positions in Q1 2019 and 3 closed out, a net change of -2 holders.
- The largest Psychemedics Corporation buyer in Q1 2019 was Kennedy Capital Management, an estimated $1.36M added.
- The largest Psychemedics Corporation seller in Q1 2019 was LSV Asset Management, an estimated $531K sold.
Based on aggregated 13F filings for Q1 2019.